Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Ruibai Luo, Ph.D.

Program Director
Division of Cancer Biology (DCB)
Cancer Cell Biology Branch
240-760-7475
|
luoru@mail.nih.gov

Dr. Ruibai Luo manages a grant portfolio in post-translational modifications, circadian biology, R03s, R15s, and R50s in cancer cell biology. 

In addition to her DCB responsibilities, she also a member of the Trans-NCI Extramural Awareness Group (TEAG) Forum. 

 

Background

Prior to DCB, Dr. Luo worked as a Staff Scientist in NCI’s Center for Cancer Research (CCR).  

Dr. Luo came to DCB because she wanted to view the science from a broader perspective. She says “being a program director gives me the opportunity to still be involved with the research while also being able to view it from a broader perspective.” 

 

Education

  • Ph.D., Biochemistry and Molecular Biology, City University of New York 
  • M.S., Molecular Biology, Wuhan University
  • B.S., Biochemistry, Wuhan University
Email